Regulatory Mechanisms, Research Methods, and Modification-Omics Analysis of Protein Post-Translational Modifications
Regulatory Mechanisms, Research Methods, and Modification-Omics Analysis of Protein Post-Translational Modifications
Protein post-translational modifications (PTMs) broadly refer to covalent processing events that occur during or after translation, including proteolytic cleavage and the covalent addition or removal of chemical groups, small molecules, or protein modifiers, thereby regulating protein activity, stability, subcellular localization, and molecular interactions. Phosphorylation, ubiquitination, SUMOylation, glycosylation, methylation, acetylation, lactylation, and other modifications jointly participate in signal transduction, metabolic regulation, gene expression, DNA damage repair, and immune responses .
Keywords: protein post-translational modifications; ubiquitination; SUMOylation; phosphorylation; glycosylation; methylation; acetylation; lactylation; modification proteomics; mass spectrometry analysis
1 Types and Functions of Protein Post-Translational Modifications
1.1 Regulatory Roles of Protein Post-Translational Modifications
Post-translational modifications can alter the charge, steric properties, and chemical characteristics of amino acid residues, thereby affecting protein conformation, enzymatic activity, stability, subcellular localization, and protein interactions. The same protein may undergo multiple modifications at different residues, and different modifications may exhibit cooperative, competitive, or sequential regulation, thereby expanding the structural and functional diversity of the proteome.
1.2 Common Types of Post-Translational Modifications
Protein post-translational modifications include phosphorylation, ubiquitination, SUMOylation, glycosylation, methylation, acetylation, lactylation, S-nitrosylation, lipidation, palmitoylation, myristoylation, carbamylation, and proteolytic processing. Different modifications have distinct substrate residues, catalytic systems, and biological functions.

Figure 1 Common types of protein post-translational modifications and their target residues
Table 1 Major Characteristics of Common Protein Post-Translational Modifications
Modification Type | Major Modified Residues or Sites | Major Regulatory System | Major Biological Functions |
Ubiquitination | Mainly lysine; may also occur at the protein N terminus and other sites | E1, E2, E3, and deubiquitinating enzymes | Protein degradation, signal transduction, membrane trafficking, and DNA damage repair |
SUMOylation | Lysine | SUMO E1, Ubc9, SUMO E3, and SENP | Protein stability, nucleocytoplasmic transport, transcriptional regulation, and DNA repair |
Phosphorylation | Serine, threonine, and tyrosine | Protein kinases and protein phosphatases | Signal transduction, enzymatic activity, cell cycle, and apoptosis |
Glycosylation | Asparagine, serine, threonine, or tryptophan | Glycosyltransferases and glycosidases | Protein folding, secretion, transport, recognition, and cell adhesion |
Methylation | Lysine and arginine | Methyltransferases and demethylases | Chromatin regulation, gene transcription, and protein interactions |
Acetylation | Protein N terminus and lysine | Acetyltransferases and deacetylases | Chromatin regulation, metabolism, nuclear transport, and protein stability |
Lactylation | Lysine | Lactate metabolism, acyl donors, and associated modification processes | Gene expression, inflammatory regulation, and adaptation to the tumor microenvironment |
S-Nitrosylation | Cysteine | Nitric oxide-associated reaction systems | Redox signaling, enzymatic activity, and stress responses |
Lipidation | Glycine, cysteine, and other residues | Acyltransferase and deacylation systems | Membrane localization, protein trafficking, and signaling-complex assembly |
Proteolytic processing | Specific peptide bonds | Specific proteases | Protein maturation, signal-peptide removal, and zymogen activation |
2 Research Workflow for Modification Proteomics
2.1 Sample Preparation and Protein Digestion
Total proteins are extracted after lysis of tissue, cell, or body-fluid samples and are then reduced, alkylated, and digested with proteases to generate peptide mixtures. During sample preparation, protease inhibitors, phosphatase inhibitors, deubiquitinating enzyme inhibitors, or deacetylase inhibitors should be added according to the target modification to reduce modification loss caused by sample processing.
2.2 Enrichment of Modified Peptides
Most modified peptides are present at low abundance and require selective enrichment before mass spectrometric detection. Phosphopeptides can be enriched by immobilized metal ion affinity chromatography or metal oxide affinity methods; glycopeptides can be enriched using lectins, hydrophilic interaction chromatography, or chemical derivatization; ubiquitination sites can be enriched using antibodies that recognize the diglycine remnant on lysine residues after tryptic digestion; and acetylated, methylated, and lactylated peptides can be enriched using modification-specific antibodies.
2.3 Mass Spectrometric Detection and Site Localization
Liquid chromatography-tandem mass spectrometry can identify modification types according to precursor-ion mass shifts and determine peptide sequences and modification sites using tandem mass spectrometric fragment ions. When the same peptide contains multiple candidate modification residues, site-localization probability, diagnostic fragment ions, and results from replicate samples should be combined to evaluate site confidence.
2.4 Bioinformatics Analysis
After database searching of mass spectrometric data, information on modified peptides, modification sites, and corresponding proteins can be obtained, followed by differential-modification analysis, sequence-motif analysis, protein functional annotation, subcellular-localization analysis, signaling-pathway enrichment, and protein-interaction network analysis. Modification-omics data should also be integrated with total proteomic data to distinguish changes in modification stoichiometry from changes in total protein abundance.
2.5 Phenotypic and Mechanistic Validation
Candidate modification sites can be validated using amino acid mutagenesis, protein knockdown or knockout, treatment with modification-enzyme inhibitors, and recombinant protein experiments. Mechanistic studies can further analyze the effects of modification sites on enzymatic activity, protein stability, subcellular localization, complex formation, and cellular phenotypes.
Table 2 Major Research Stages in Modification Proteomics
Research Stage | Main Content | Common Methods |
Protein extraction | Obtain and preserve proteins and their modification states | Low-temperature lysis, inhibitor treatment, and protein quantification |
Protein digestion | Convert proteins into peptides suitable for mass spectrometric analysis | Trypsin, Lys-C, or combined digestion with multiple proteases |
Modified-peptide enrichment | Improve detection of low-abundance modified peptides | Affinity enrichment, antibody enrichment, chemical derivatization, and chromatographic separation |
Mass spectrometric detection | Identify modification types, peptides, and sites | LC-MS/MS and high-resolution mass spectrometry |
Data analysis | Identify differential sites and related pathways | Database searching, quantitative analysis, motif analysis, and pathway analysis |
Functional validation | Confirm the biological roles of modification sites | Site-directed mutagenesis, KD/KO, inhibitors, and functional assays |
Mechanistic validation | Analyze regulatory enzymes, substrates, and interaction networks | IP, pull-down, recombinant proteins, and animal models |
3 Databases and Visualization Tools for Post-Translational Modification Research
3.1 Protein and Enzyme Databases
UniProt can be used to query protein sequences, functions, subcellular localization, and known modification sites; PIR provides protein-sequence classification and functional annotation information; and BRENDA is mainly used to query enzymatic reactions, substrates, kinetic parameters, and inhibitors.
3.2 Post-Translational Modification Databases
PhosphoSitePlus integrates information on phosphorylation, ubiquitination, acetylation, methylation, and other modifications of mammalian proteins; PTMD collects evidence linking post-translational modifications with human diseases; and PROSITE can identify functional domains, conserved motifs, and potential functional regions based on protein sequences.
3.3 Protein Structure and Site Visualization
PyMOL and Chimera can be used to display protein three-dimensional structures, the locations of modified residues, and their spatial relationships with ligands or interacting proteins. Modification sites can be mapped onto protein domains, catalytic centers, or molecular interaction interfaces to analyze their potential effects on protein function.
Table 3 Common Databases and Software Used in Post-Translational Modification Research
Type | Database or Software | Main Application |
Comprehensive protein database | UniProt | Querying protein sequences, functions, localization, and modification sites |
Protein information database | PIR | Protein-sequence classification and functional annotation |
Enzyme database | BRENDA | Querying enzymatic reactions, substrates, kinetic parameters, and inhibitors |
Modification database | PhosphoSitePlus | Querying mammalian protein post-translational modification information |
Disease-associated modification database | PTMD | Querying associations between PTMs and human diseases |
Sequence-motif database | PROSITE | Analysis of functional domains and conserved sequence motifs |
Three-dimensional structure software | PyMOL | Visualization of modification sites and protein three-dimensional structures |
Three-dimensional structure software | Chimera | Analysis of molecular structures, interaction interfaces, and domains |
4 Protein Ubiquitination
4.1 Ubiquitination Reaction Process
Ubiquitination is sequentially catalyzed by ubiquitin-activating enzyme E1, ubiquitin-conjugating enzyme E2, and ubiquitin ligase E3. E1 uses ATP to activate ubiquitin and forms a thioester bond with the C terminus of ubiquitin; activated ubiquitin is then transferred to a cysteine residue of E2; and E3 recognizes the substrate protein and promotes attachment of ubiquitin to lysine or another acceptor site on the substrate.
4.2 Ubiquitin-Chain Types and Their Functions
Substrate proteins may undergo monoubiquitination, multisite monoubiquitination, or polyubiquitination. K48-linked polyubiquitin chains mainly participate in proteasomal degradation, whereas K63-linked ubiquitin chains mainly participate in signal transduction, membrane trafficking, DNA damage repair, and autophagy regulation. Ubiquitin can also form different chain types through K6, K11, K27, K29, K33, M1, and other linkage sites.
4.3 Regulation by Deubiquitination
Deubiquitinating enzymes can remove ubiquitin from substrate proteins or edit ubiquitin-chain structures, making ubiquitination a dynamic and reversible regulatory process. Abnormalities in ubiquitin ligases, deubiquitinating enzymes, or proteasomal activity can disrupt protein homeostasis and affect the cell cycle, apoptosis, immunity, and tumor-related signaling.
4.4 Methods for Ubiquitination Research
Ubiquitination can be studied using activity-based probes to detect the activities of ubiquitination enzymes or deubiquitinating enzymes, while ubiquitin tags, immunoprecipitation-immunoblotting, and mass spectrometric analysis can be used to evaluate ubiquitination of target proteins. Ubiquitinomics generally combines enrichment of diglycine-remnant peptides with high-resolution mass spectrometry to systematically analyze ubiquitination sites and their changes.
5 Protein SUMOylation
5.1 SUMO Maturation and Transfer
SUMO precursors are first processed by SUMO-specific proteases to expose the C-terminal diglycine motif and form mature SUMO. Mature SUMO is activated by E1 in an ATP-dependent manner and transferred to E2 Ubc9, which can directly catalyze formation of an isopeptide bond between SUMO and a substrate lysine; SUMO E3 ligases enhance substrate selectivity and conjugation efficiency in many reactions but are not essential for all SUMOylation events .
5.2 Regulation by DeSUMOylation
SENP-family proteins participate in both SUMO-precursor processing and removal of SUMO from substrate proteins. The dynamic balance between SUMO conjugation and deSUMOylation determines the modification level, subcellular localization, and functional state of substrate proteins.
5.3 Biological Functions of SUMOylation
SUMOylation mainly participates in protein stability, nucleocytoplasmic transport, transcriptional regulation, chromatin organization, cell-cycle regulation, and DNA damage repair. SUMOylation generally does not directly mediate proteasomal degradation but can affect substrate stability by altering protein interactions or through crosstalk with the ubiquitin system.
6 Protein Phosphorylation
6.1 Phosphorylation and Dephosphorylation
Canonical eukaryotic serine/threonine and tyrosine kinases mainly transfer the γ-phosphate group of ATP to serine, threonine, or tyrosine residues on substrate proteins, whereas residues such as histidine and aspartate can also undergo noncanonical phosphorylation. The phosphate group can alter local charge, protein conformation, and molecular-binding capacity, whereas protein phosphatases terminate or readjust signaling by removing phosphate groups.
6.2 Biological Functions of Phosphorylation
Phosphorylation can rapidly regulate enzymatic activity, receptor signaling, and protein interactions and participates in cell proliferation, differentiation, metabolism, the cell cycle, apoptosis, and immune responses. Consecutive kinase and phosphatase reactions can form signaling cascades, feedback regulation, and pathway crosstalk.
6.3 Methods for Phosphorylation Research
Phosphorylation can be studied using kinase activity assays, phosphatase treatment, radioactive ATP labeling, phosphorylation-specific antibodies, ELISA, antibody arrays, flow cytometry, and phosphoproteomics. Phosphopeptide enrichment is generally required before mass spectrometric analysis to improve detection of low-abundance phosphorylation sites.
7 Protein Glycosylation
7.1 Major Types of Glycosylation
(1) N-Glycosylation
N-glycosylation mainly occurs on asparagine residues, is initiated in the endoplasmic reticulum, and is further processed in the Golgi apparatus, participating in protein folding, quality control, transport, and secretion.
(2) O-Glycosylation
O-glycosylation mainly occurs on serine or threonine residues, and its glycan structures and modification sites are highly diverse, participating in mucin formation, cellular signaling, and regulation of protein stability.
(3) C-Glycosylation
C-glycosylation mainly involves formation of a carbon-carbon bond between a glycan and a specific tryptophan residue. C-mannosylation is a common form and can affect protein folding, secretion, and receptor function.
7.2 Biological Functions of Glycosylation
Glycosylation is widely present in secreted and membrane proteins and can regulate protein folding, degradation, secretion, transport, and clearance while also participating in cell adhesion, cell recognition, receptor activation, endocytosis, and immune responses. Certain glycosylation modifications in the nucleus and cytoplasm have relatively simple structures but are highly dynamic .
7.3 Methods for Glycosylation Research
Glycosylation can be studied through lectin binding, glycosidase treatment, glycosyltransferase activity assays, chromatographic separation, and mass spectrometric analysis. Glycoproteomics generally uses lectin affinity, hydrophilic interaction, or chemical-labeling methods to enrich glycoproteins and glycopeptides, followed by mass spectrometry to identify glycan composition, glycosylation sites, and carrier proteins.
8 Protein Methylation
8.1 Lysine Methylation
The ε-amino group of the lysine side chain can undergo monomethylation, dimethylation, and trimethylation. Different degrees of methylation and modification sites can generate distinct protein-recognition interfaces and participate in heterochromatin formation, activation or repression of gene transcription, and DNA damage responses.
8.2 Arginine Methylation
Arginine can undergo monomethylation, asymmetric dimethylation, and symmetric dimethylation. Arginine methylation can regulate RNA binding, protein interactions, transcriptional regulation, signal transduction, and nucleocytoplasmic transport.
8.3 Methods for Methylation Research
Protein methylation can be detected using modification-specific antibodies, immunoblotting, immunofluorescence, immunoprecipitation, and mass spectrometric analysis. Histone methylation can also be studied using ChIP-qPCR or ChIP sequencing to analyze the distribution of specific modifications across chromatin regions and their relationships with gene transcription.
9 Protein Acetylation
9.1 Major Forms of Acetylation
Protein acetylation mainly includes N-terminal acetylation and lysine acetylation. N-terminal acetylation occurs at the protein N terminus and is generally relatively stable, whereas lysine acetylation is catalyzed by lysine acetyltransferases and can be removed by histone deacetylases or Sirtuin-family proteins.
9.2 Regulatory Roles of Acetylation
Lysine acetylation can neutralize the positive charge of lysine and alter protein binding to DNA, RNA, or other proteins. Acetylation participates in chromatin opening, gene expression, metabolic-enzyme activity, protein stability, nucleocytoplasmic transport, cell-cycle regulation, and cytoskeletal regulation.
9.3 Methods for Acetylation Research
Acetylation can be analyzed using pan-acetyllysine antibodies or site-specific antibodies for immunoblotting, immunofluorescence, and immunoprecipitation, as well as through acetyltransferase or deacetylase activity assays and mass spectrometric analysis. Acetylproteomics generally combines enrichment using anti-acetyllysine antibodies with LC-MS/MS identification of differentially modified sites.
10 Protein Lactylation
10.1 Metabolic Basis of Lactylation
Lactylation is a lysine acylation modification that connects lactate metabolism with regulation of protein function. Enhanced glycolysis, hypoxia, or lactate accumulation can alter intracellular levels of lactate and related metabolic intermediates, thereby affecting lysine lactylation of histone and nonhistone proteins .
10.2 Biological Functions of Lactylation
Histone lactylation can affect chromatin states and gene expression and participates in inflammatory regulation, immune-cell function, tumor immune evasion, tumor-cell migration, angiogenesis, treatment resistance, and extracellular-matrix remodeling. Lactylation levels are also affected by lactate production, lactate transport, oxygen supply, and cellular metabolic status.
10.3 Methods for Lactylation Research
Lactylation can be analyzed using pan-lysine-lactylation antibodies for immunoblotting, immunofluorescence, and immunoprecipitation. Liquid chromatography-tandem mass spectrometry can identify lactylated peptides and specific sites and can be used to compare changes in the lactylated proteome under different treatment conditions.
11 Experimental Design for Post-Translational Modification Research
11.1 Sample Processing and Preservation of Modifications
Protein extraction should be performed under low-temperature conditions, and lysis-buffer composition, sample-processing time, and centrifugation conditions should remain consistent among groups. For highly dynamic modifications, cellular reactions should be terminated rapidly and corresponding inhibitors should be added to prevent dephosphorylation, deubiquitination, or deacetylation during sample processing.
11.2 Modification Enrichment and Total-Protein Correction
Modification-omics requires not only comparison of modified-peptide abundance but also measurement of the total abundance of corresponding proteins. An increase in a target modification may result from an increased modification ratio per unit of protein or from an increase in total protein abundance. Therefore, modification signals should be corrected using total-proteomic data, target-protein immunoblotting, or immunoprecipitation results.
11.3 Site Identification and Functional Mutagenesis
Candidate sites identified by mass spectrometry should be screened using localization probability, replicate samples, fragment-ion coverage, and modified-peptide abundance. For functional validation, lysine, serine, threonine, or tyrosine can be replaced with residues that cannot accept the corresponding modification, followed by comparison of protein activity, stability, localization, and cellular phenotypes before and after mutation.
11.4 Combined Analysis of Multiple Modifications
The same protein may simultaneously undergo phosphorylation, ubiquitination, acetylation, methylation, or lactylation, and different modifications may exhibit cooperative, competitive, or sequential regulation. Combined analysis should integrate site proximity, temporal changes, modification-enzyme activity, and protein function and should avoid directly interpreting changes in a single modification as the final biological effect.
11.5 Common Problems in Result Interpretation
Problem | Possible Cause | Analysis and Improvement Strategy |
Weak modification signal | Low modification abundance, sample degradation, or insufficient enrichment efficiency | Increase the starting sample amount, shorten processing time, and optimize enrichment conditions |
Unstable modification differences among groups | Insufficient biological replicates or inconsistent sample processing | Increase biological replicates and standardize lysis, digestion, and enrichment procedures |
Modification increases together with total protein | Changes in protein expression cause an apparent increase in modification | Normalize modification signals to total protein abundance |
Unclear mass-spectrometric site localization | Multiple candidate residues are present within the peptide | Examine localization probabilities and fragment ions and perform site-directed mutagenesis |
Inconsistent antibody and mass-spectrometric results | Antibody specificity, epitope masking, or different detection ranges | Validate using an independent antibody, IP-MS, or targeted mass spectrometry |
Inhibitor treatment causes broad phenotypes | The inhibitor has off-target effects or affects multiple substrates | Combine genetic intervention with recombinant-enzyme experiments for validation |
12 Products Related to Protein Post-Translational Modification Research
Modification or Research Type | Name | CAS No. | Main Research Application |
SUMOylation | 2-D08 | Inhibits Ubc9-mediated SUMO transfer and is used for SUMOylation-pathway intervention and substrate-function research | |
Ubiquitination | BC-1382 | Used for research on E3 ubiquitin ligase HECTD2-associated regulation, substrate ubiquitination, and protein stability | |
Ubiquitination | Heclin | HECT-type E3 ubiquitin ligase inhibitor used for research on the NEDD4, SMURF, and WWP families | |
Ubiquitination | NSC 624206 | Ubiquitin-activating enzyme E1 inhibitor used for E1-dependent ubiquitin activation and protein-homeostasis research | |
Ubiquitination | NSC-632839 | Ubiquitin isopeptidase inhibitor used for deubiquitinating-enzyme activity, ubiquitin-chain stability, and accumulation of substrate ubiquitination | |
Ubiquitination | PYR-41 | Ubiquitin-activating enzyme E1 inhibitor used to analyze overall ubiquitination levels and substrate stability | |
Ubiquitination | PYZD 4409 | UBA1 inhibitor used to study initiation of the ubiquitination cascade and E1-dependent protein degradation | |
Ubiquitination | TCID | UCHL3 inhibitor used for research on deubiquitination, ubiquitin-chain editing, and substrate stability | |
Ubiquitination and protein degradation | MG132 | Proteasome inhibitor used to validate ubiquitin-proteasome-dependent degradation | |
Ubiquitination sample processing | N-Ethylmaleimide | Alkylates thiols and inhibits certain cysteine-type deubiquitinating enzymes, thereby preserving ubiquitination states in samples | |
Ubiquitination sample processing | Iodoacetamide | Alkylates cysteine and is used in proteomic sample preparation to reduce interference from deubiquitination reactions | |
Phosphorylation | Adenosine 5′-Triphosphate Disodium Salt | Provides phosphate groups for in vitro kinase reactions and is used for protein kinase activity and substrate-phosphorylation research | |
Phosphorylation | DiFMUP | Fluorescent phosphatase substrate used for protein phosphatase activity assays and inhibitor screening | |
Phosphorylation | Sodium Orthovanadate | Protein tyrosine phosphatase inhibitor used to preserve tyrosine-phosphorylation states and study signaling pathways | |
Phosphorylation | Sodium Fluoride | Serine/threonine phosphatase inhibitor commonly used to preserve phosphorylation states during protein extraction | |
Phosphorylation | β-Glycerophosphate Disodium Salt Pentahydrate | Phosphatase-inhibitor component used to reduce dephosphorylation during protein extraction | |
Glycosylation | UDP-Glucose Disodium Salt | Used as an activated sugar donor for in vitro glycosyltransferase reactions and glucosylation research | |
Glycosylation | UDP-Galactose Sodium Salt | Used for galactosyltransferase reactions and formation of different glycan structures | |
Glycosylation | p-Nitrophenyl-β-D-Glucopyranoside | Chromogenic β-glucosidase substrate used for glycosidase activity assays | |
Glycosylation | Tunicamycin | Inhibits initiation of N-glycosylation and is used for endoplasmic reticulum stress, protein-folding, and glycosylation-function research | |
Glycosylation | Swainsonine | α-Mannosidase II inhibitor used for complex N-glycan processing and glycan-maturation research | |
Glycosylation | Kifunensine | Endoplasmic reticulum α-mannosidase I inhibitor used for high-mannose N-glycans and glycoprotein quality-control research | |
Glycosylation | PUGNAc | O-GlcNAcase inhibitor used to increase protein O-GlcNAc modification levels and study dynamic regulation | |
Methylation | L-Methionine | Used for SAM synthesis, methyl-donor formation, and methionine-dependence research | |
Methylation | S-Adenosyl-L-Methionine | Used as a methyl donor for protein methyltransferase reactions and methyltransferase activity research | |
Methylation | S-Adenosyl-L-Homocysteine | Used as a methyltransferase reaction product to analyze product inhibition and SAM/SAH balance | |
Methylation | Sinefungin | SAM-competitive methyltransferase inhibitor used for protein and nucleic acid methylation research | |
Methylation | BIX 01294 | G9a/GLP histone lysine methyltransferase inhibitor used for H3K9 methylation and chromatin-regulation research | |
Methylation | GSK-J4 | KDM6-family demethylase inhibitor used for H3K27 methylation and inflammatory transcriptional regulation | |
Acetylation | Trichostatin A | Broad-spectrum HDAC inhibitor used to increase histone and nonhistone protein acetylation | |
Acetylation | Vorinostat | HDAC inhibitor used for chromatin regulation, protein acetylation, and tumor-related research | |
Acetylation | Sodium Butyrate | HDAC inhibitor used for histone acetylation, gene expression, and cell-differentiation research | |
Acetylation | Nicotinamide | NAD⁺-dependent Sirtuin inhibitor used for deacetylation and cellular-metabolism regulation research | |
Lactylation | L-Lactic Acid | Used for exogenous lactate supplementation and research on the relationship between lactate metabolism and lactylation | |
Lactylation | Sodium L-Lactate | Used to establish lactate-supplementation models and analyze cellular lactate levels and lysine-lactylation changes | |
Lactylation | Sodium Pyruvate | Used to regulate the lactate-pyruvate metabolic balance and as a control for lactate-metabolism intervention | |
Lactylation | 2-Deoxy-D-Glucose | Inhibits glycolysis and is used to analyze the effects of reduced endogenous lactate production on lactylation | |
Lactylation | Sodium Oxamate | Lactate dehydrogenase inhibitor used to interfere with lactate production and lactylation | |
Lactylation | FX11 | LDHA inhibitor used for glycolysis, lactate production, and lactylation-regulation research | |
Protein palmitoylation | 2-Bromopalmitic Acid | Acylation inhibitor used for protein palmitoylation, membrane localization, and signal-transduction research | |
Protein palmitoylation | Palmitic Acid | Used for fatty acid supplementation, protein acylation, and lipotoxicity-related research | |
Protein myristoylation | Myristic Acid | Used for protein myristoylation, membrane binding, and lipid-metabolism research | |
S-Nitrosylation | S-Nitrosoglutathione | Nitric oxide donor used for protein S-nitrosylation and redox-signaling research | |
S-Nitrosylation | Sodium Nitroprusside Dihydrate | Nitric oxide donor used for NO signaling and protein nitrosylation research | |
S-Nitrosylation detection | Ascorbic Acid | Used in the biotin-switch method to selectively reduce S-nitrosothiols and assist in detecting protein S-nitrosylation |
References
[1] Zhong Q, et al. Protein Posttranslational Modifications in Health and Diseases: Functions, Regulatory Mechanisms, and Therapeutic Implications. MedComm (2020). 2023 May 2;4(3):e261.
[2] Luo P, et al. The Role of SUMOylation in the Neurovascular Dysfunction After Acquired Brain Injury. Front Pharmacol. 2023 Mar 22;14:1125662.
[3] Reily C, et al. Glycosylation in Health and Disease. Nat Rev Nephrol. 2019 Jun;15(6):346-366.
[4] Izzo LT, et al. Histone Lactylation Links Metabolism and Gene Regulation. Nature. 2019 Oct;574(7779):492-493.
For more related articles, please see below:
[1] Phosphorylated and Sulfonated Peptides
[2] Glycosylation in Biopharmaceuticals
[3] Structural Coding of the Ubiquitin System and Mechanisms of Protein Homeostasis Regulation
危险品化学品经营许可证(带存储)